Randomized trial shows vitamin D improves leukocyte count in runners and non-runners, indicating better immune responses.
This study investigated the effects of an 8-week daily 2000 IU vitamin D₃ supplementation, administered via orodispersible films, on serum vitamin D, leukocyte count, and performance parameters in healthy recreational runners and non-runners, followed by a 12-week post-supplementation follow-up. Forty-five participants were randomized into four groups: supplemented runners (RUN-SUPPL, n = 13, age 33.4 ± 7.5 y), non-supplemented runners (RUN-CON, n = 10, age 34.8 ± 8.6 y), supplemented non-runners (NON-RUN-SUPPL, n = 11, age 29.3 ± 7.5 y), and non-supplemented non-runners (NON-RUN-CON, n = 11, age 28.3 ± 6.0 y). Assessments were conducted at baseline (T0, October, pre-supplementation), post-intervention (T1, December, after 8 weeks), and follow-up (T2, March, 12-weeks post-supplementation). Supplementation significantly increased serum 25(OH)D₃ in runners (30.45 ± 7.0 to 35.35 ± 8.9 ng/mL, p < 0.001) and non-runners (25.0 ± 8.7 to 30.2 ± 9.7 ng/mL, p < 0.001), while non-supplemented non-runners showed a marked decline (25.93 ± 6.6 to 17.8 ± 7.3 ng/mL, p < 0.001). After follow-up, serum vitamin D decreased significantly in all groups (e.g., RUN-SUPPL 23.52 ± 5.6 ng/mL, p < 0.001). A significant time-by-supplementation interaction was observed for total leukocytes ( p = 0.001) and neutrophils ( p = 0.03), indicating more stable immune profiles in supplemented participants. No significant changes were found in VO₂max or countermovement jump ( p > 0.05), while maximal isometric force showed a trend toward improvement in supplemented subjects ( p = 0.056). Despite these physiological benefits, no ergogenic effects on aerobic or explosive performance were observed.
No takes yet. Share an insight, caveat, or question.
Gervasi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: